Company intelligence / Profile preview
Shanghai Baize Medical Technology
Shanghai, Shanghai, Chinabaizemed.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Shanghai Baize Medical Technology is a clinical-stage biotechnology company focused on the research and development of next-generation cell therapies for oncology. The company specializes in Chimeric Antigen Receptor T-cell (CAR-T) technologies designed to treat solid tumors, which remain a significant challenge in immunotherapy. Baize Medical's pipeline includes several candidates targeting Glypican-3 (GPC3) and HER2, with a primary focus on liver cancer and other refractory solid malignancies. By optimizing CAR-T cell persistence and infiltration, the company seeks to provide curative options for patients with advanced cancers.
- Therapeutic areas
- Oncology
- Modalities
- CAR-T cell therapyCell therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Shanghai Baize Medical Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Baize Medical Technology.